Diagnostic Tests Afshin Ostovar Bushehr University of Medical Sciences Bushehr, 2013 12/7/20151.

Slides:



Advertisements
Similar presentations
PERSONALIZED MEDICINE: Planning for the Future You, Your Biomarkers and Your Rights.
Advertisements

Validity and Reliability of Analytical Tests. Analytical Tests include both: Screening Tests Diagnostic Tests.
Lecture 3 Validity of screening and diagnostic tests
SCREENING CHP400: Community Health Program-lI Mohamed M. B. Alnoor
1 Case-Control Study Design Two groups are selected, one of people with the disease (cases), and the other of people with the same general characteristics.
Azita Kheiltash Social Medicine Specialist Tehran University of Medical Sciences Diagnostic Tests Evaluation.
1 Comunicación y Gerencia 18/4/2011Dr Salwa Tayel (Screening) بسم الله الرحمن الرحيم.
Statistics for Health Care
Principles of Epidemiology Lecture 12 Dona Schneider, PhD, MPH, FACE
Chronic diseases 1.Chronic diseases have long and variable preclinical phases. 2.The preclinical phase is that portion of the disease natural history during.
Screening for Disease Guan Peng Department of Epidemiology School of Public Health, CMU.
(Medical) Diagnostic Testing. The situation Patient presents with symptoms, and is suspected of having some disease. Patient either has the disease or.
Screening and Early Detection Epidemiological Basis for Disease Control – Fall 2001 Joel L. Weissfeld, M.D. M.P.H.
Screening Sherine Shawky, MD, Dr.PH Assistant Professor Public Health King Abdulaziz University College of Medicine
What is Screening? Basic Public Health Concepts Sheila West, Ph.D. El Maghraby Professor of Ophthalmology Wilmer Eye Institute Johns Hopkins University.
BASIC STATISTICS: AN OXYMORON? (With a little EPI thrown in…) URVASHI VAID MD, MS AUG 2012.
The Nature of Disease.
Multiple Choice Questions for discussion
Agency for Healthcare Research and Quality Advancing Excellence in Health Care Provision of Preventive Services in the Complex Patient AHRQ.
Mother and Child Health: Research Methods G.J.Ebrahim Editor Journal of Tropical Pediatrics, Oxford University Press.
Lecture 4: Assessing Diagnostic and Screening Tests
HSS4303B Intro to Epidemiology Feb 4, 2010 – Screening Tests.
Division of Population Health Sciences Royal College of Surgeons in Ireland Coláiste Ríoga na Máinleá in Éirinn Indices of Performances of CPRs Nicola.
Statistics for Health Care Biostatistics. Phases of a Full Clinical Trial Phase I – the trial takes place after the development of a therapy and is designed.
Principles and Predictive Value of Screening. Objectives Discuss principles of screening Describe elements of screening tests Calculate sensitivity, specificity.
Reliability of Screening Tests RELIABILITY: The extent to which the screening test will produce the same or very similar results each time it is administered.
Vanderbilt Sports Medicine How to practice and teach EBM Chapter 3 May 3, 2006.
EVIDENCE ABOUT DIAGNOSTIC TESTS Min H. Huang, PT, PhD, NCS.
CHP400: Community Health Program-lI Mohamed M. B. Alnoor Muna M H Diab SCREENING.
· Lecture 31 & 32 : Scope of clinical biochemistry ط Uses of clinical biochemistry tests ط Diagnosis, Prognosis, Screening, Monitoring ط Reporting results.
Calculating sample size for means Afshin Ostovar Bushehr University of Medical Sciences.
Screening Puja Myles
Cost-effectiveness of Screening Tests Mark Hlatky, MD Stanford University.
Prediction statistics Prediction generally True and false, positives and negatives Quality of a prediction Usefulness of a prediction Prediction goes Bayesian.
Screening of diseases Dr Zhian S Ramzi Screening 1 Dr. Zhian S Ramzi.
SCREENING TTTThe search for unrecognized disease or defect by means of rapidly applied tests, examinations or other procedures in apparently healthy.
Principles of Screening
Screening and its Useful Tools Thomas Songer, PhD Basic Epidemiology South Asian Cardiovascular Research Methodology Workshop.
1 Wrap up SCREENING TESTS. 2 Screening test The basic tool of a screening program easy to use, rapid and inexpensive. 1.2.
The Bone & Joint Decade - India An IRACON 2003 Indian Rheumatology: New Horizons, New Hopes Artichoke of Population Studies & Clinical Practice Dr Rajesh.
Diagnostic Tests Studies 87/3/2 “How to read a paper” workshop Kamran Yazdani, MD MPH.
Unit 15: Screening. Unit 15 Learning Objectives: 1.Understand the role of screening in the secondary prevention of disease. 2.Recognize the characteristics.
The Diagnostic Process A BRIEF OVERVIEW diagnostic process What is it? to figure out to problem solve method scheme.
Screening.  “...the identification of unrecognized disease or defect by the application of tests, examinations or other procedures...”  “...sort out.
10 May Understanding diagnostic tests Evan Sergeant AusVet Animal Health Services.
EVALUATING u After retrieving the literature, you have to evaluate or critically appraise the evidence for its validity and applicability to your patient.
Prediction research Introduction and examples A. Cecile J.W. Janssens, PhD Professor of Translational Epidemiology.
BIOSTATISTICS Lecture 2. The role of Biostatisticians Biostatisticians play essential roles in designing studies, analyzing data and creating methods.
12/12/2009Dr. Salwa Tayel1 Comunicación y Gerencia.
SCREENING FOR DISEASE. Learning Objectives Definition of screening; Principles of Screening.
© 2010 Jones and Bartlett Publishers, LLC. Chapter 12 Clinical Epidemiology.
Sensitivity, Specificity, and Receiver- Operator Characteristic Curves 10/10/2013.
Screening Tests: A Review. Learning Objectives: 1.Understand the role of screening in the secondary prevention of disease. 2.Recognize the characteristics.
دکتر حمیدرضا صابری
CHP400: Community Health Program-lI Mohamed M. B. Alnoor Muna M H Diab SCREENING.
DR.FATIMA ALKHALEDY M.B.Ch.B;F.I.C.M.S/C.M
Principles of Epidemiology E
Indian Rheumatology: New Horizons, New Hopes
Dr. Tauseef Ismail Assistant Professor Dept of C Med. KGMC
Comunicación y Gerencia
What is Screening? Basic Public Health Concepts Sheila West, Ph.D.
How do we delay disease progress once it has started?
Diagnosis II Dr. Brent E. Faught, Ph.D. Assistant Professor
What is Screening? Basic Public Health Concepts Sheila West, Ph.D.
Screening, Sensitivity, Specificity, and ROC curves
PICO model for developing EBM questions
—ROC curves for each simple test compared with NCS (gold standard) plotting the sensitivity versus 1-specificity (the false-positive rate) for different.
Introduction to Evidence Based Medicine
Evidence Based Diagnosis
Presentation transcript:

Diagnostic Tests Afshin Ostovar Bushehr University of Medical Sciences Bushehr, /7/20151

A normal individual is a person; Who has not been sufficiently examined 12/7/20152

Introduction It is necessary to distinguish between people in the population who have the disease and those who do not. clinical arena Public health arena How good is the test in separating populations of people with and without the disease in question? 12/7/20153

Biologic Variation of Human Populations 12/7/20154 Bimodal curve

12/7/20155 Unimodal curve

Validity of screening Tests Sensitivity: o the ability of the test to identify correctly those who have the disease. Specificity: o the ability of the test to identify correctly those who do not have the disease. 12/7/20156

Tests with Dichotomous Results 12/7/20157 Gold Standard

12/7/20158

False Positive effects Burden on the health care system Labeling effect 12/7/20159

False Negative effects Deprivation from effective treatment It depends on: the nature and severity of the disease the effectiveness of available intervention measure Whether the effectiveness is greater if the intervention is administered early in the natural history of the disease 12/7/201510

Tests of Continuous Variables 12/7/ Sensitivity= 5/20 = 25% Specificity= 18/20 = 90%

Tests of Continuous Variables 12/7/ Sensitivity= 17/20 = 85% Specificity= 6/20 = 30%

Different cut-offs 12/7/201513

12/7/201514

12/7/201515

12/7/201516

12/7/201517

12/7/201518

Multiple Tests Sequential (Two-stage) Testing Simultaneous (Parallel) Testing 12/7/201519

Sequential (Two-stage) Testing 12/7/201520

Test 1 Diabetes + _ Test Results + _ /7/201521

Prevalence = 5% Diabetes + _ Test Results + _ /7/201522

Sensitivity = 70% Diabetes + _ Test Results +350 _ /7/201523

Specificity = 80% Diabetes + _ Test Results _ /7/201524

Final Result of Test 1 Diabetes + _ Test Results _ /7/201525

Test 2 Diabetes + _ Test Results + _ /7/201526

Sensitivity= 90% Diabetes + _ Test Results +315 _ /7/201527

Specificity=90% Diabetes + _ Test Results _ /7/201528

Final Result of two Tests Diabetes + _ Test Results _ /7/ Net sensitivity = 315/500 = 63% Net Specificity = 9310/9600 = 98%

Simultaneous Testing 12/7/201530

Test A 12/7/201531

Test B 12/7/201532

12/7/201533

12/7/201534

Test A 12/7/201535

Test B 12/7/201536

12/7/201537

12/7/201538

Predictive Value Predictive Value Positive If the test results are positive in this patient, what is the probability that this patient has the disease. Predictive Value Negative If the test results are negative in this patient, what is the probability that this patient do not have the disease 12/7/201539

Predictive Value Positive 12/7/201540

The predictive value is affected by two factors: o the prevalence of the disease in the population tested o the specificity of the test being used, when the disease is infrequent. 12/7/201541

Relationship between Predictive Value and Disease Prevalence 12/7/201542

Relationship between Predictive Value and Disease Prevalence 12/7/201543

Relationship between Predictive Value and Disease Prevalence 12/7/201544

12/7/201545

12/7/201546

Relationship between Predictive Value and Specificity 12/7/201547

Relationship between Predictive Value and Specificity 12/7/201548

Relationship between Predictive Value and Specificity 12/7/201549

Relationship between Predictive Value and Specificity 12/7/201550